<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR423.html">Part 423
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 423.2330  Manufacturer discount payment audit and dispute resolution.
                            </h3>
                            <p class="depth1"><em>(a)</em> Third-party Administration (TPA) audits. </p><p class="depth2"><em>(1)</em> Manufacturers  participating in the Discount Program may conduct periodic audits, no  more often than annually, directly or through third parties as specified  in this section.</p><p class="depth2"><em>(2)</em> The manufacturer must provide the TPA with 60 days notice of the  reasonable basis for the audit and a description of the information  required for the audit.</p><p class="depth2"><em>(3)</em> The manufacturer must have the right to audit a statistically  significant sample of data and information held by the TPA that were  used to determine applicable discounts for applicable drugs having NDCs  with the manufacturer's FDA-assigned labeler code(s). Such data and  information will be made available on-site, and with the exception of  work papers, such information cannot be removed from the audit site.</p><p class="depth2"><em>(4)</em> The auditor for the manufacturer may release only an opinion of  the   audit results and is prohibited from releasing other information  obtained from the audit, including work papers, to its client, employer,  or any other party.</p><p class="depth1"><em>(b)</em> Manufacturer audits. </p><p class="depth2"><em>(1)</em> A manufacturer is subject to periodic  audit by CMS no more often than annually, directly or through third  parties, as specified in this section.</p><p class="depth2"><em>(2)</em> CMS provides the manufacturer with 60 days notice of the audit  and a description of the information required for the audit.</p><p class="depth2"><em>(3)</em> CMS has the right to audit appropriate data, including data  related to a manufacturer's FDA-assigned labeler codes, NDC last lot  expiration dates, utilization, and pricing information relied on by the  manufacturer to dispute quarterly invoices, and any other data CMS  determines are necessary to carry out the Discount Program.</p><p class="depth1"><em>(c)</em> Dispute resolution. </p><p class="depth2"><em>(1)</em> Manufacturers may dispute applicable  discounts invoiced to the manufacturer on quarterly invoices by  providing notice of the dispute to the TPA in a manner specified by CMS  within 60 days of receipt of the information that is the subject of the  dispute.</p><p class="depth2"><em>(2)</em> Such notice must be accompanied by supporting evidence that is  material, specific, and related to the dispute in a manner specified by  CMS.</p><p class="depth2"><em>(3)</em> The manufacturer must not withhold any invoiced discount  payments pending dispute resolution with the sole exception of invoiced  amounts for applicable drugs that do not have labeler codes provided by  the manufacturer to CMS in accordance with Sec. 423.2306(b)(4) of this  subpart. If payment is withheld in accordance with this paragraph, the  manufacturer must notify the TPA and applicable Part D sponsors within  38 days of receipt of the applicable invoice that payment is being  withheld for this reason.</p><p class="depth2"><em>(4)</em> If the manufacturer receives an unfavorable determination from  the TPA, or the dispute is not resolved within 60 calendar days of the  TPA's receipt of the notice of dispute, the manufacturer may request  review by the independent review entity contracted by CMS within--</p><p class="depth3"><em>(i)</em> Thirty calendar days of the unfavorable determination; or</p><p class="depth3"><em>(ii)</em> Ninety calendar days after the TPA's receipt of the notice of  dispute if dispute is not resolved within 60 days, whichever is earlier.</p><p class="depth2"><em>(5)</em> The independent review entity must make a determination within  90 calendar days of receipt of the manufacturer's request for review.</p><p class="depth2"><em>(6)</em></p><p class="depth3"><em>(i)</em> CMS or a manufacturer that receives an unfavorable  determination from the independent review entity may request review by  the CMS Administrator within 30 calendar days of receipt of the  notification of such determination.</p><p class="depth3"><em>(ii)</em> The decision of the CMS Administrator is final and binding.</p><p class="depth2"><em>(7)</em> CMS adjusts future invoices (or implements an alternative  reimbursement process if determined necessary by CMS) if the dispute is  resolved in favor of the manufacturer.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
